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Abstract Previously we proposed that transmission of the hedgehog signal across the plasma
membrane by Smoothened is triggered by its interaction with cholesterol (Luchetti et al., 2016). But
how is cholesterol, an abundant lipid, regulated tightly enough to control a signaling system that
can cause birth defects and cancer? Using toxin-based sensors that distinguish between distinct
pools of cholesterol, we find that Smoothened activation and hedgehog signaling are driven by a
biochemically-defined, small fraction of membrane cholesterol, termed accessible cholesterol.
Increasing cholesterol accessibility by depletion of sphingomyelin, which sequesters cholesterol in
complexes, amplifies hedgehog signaling. Hedgehog ligands increase cholesterol accessibility in
the membrane of the primary cilium by inactivating the transporter-like protein Patched 1.
Trapping this accessible cholesterol blocks hedgehog signal transmission across the membrane.
Our work shows that the organization of cholesterol in the ciliary membrane can be modified by
extracellular ligands to control the activity of cilia-localized signaling proteins.
DOI: https://doi.org/10.7554/eLife.50051.001
Introduction
A long-standing mystery in hedgehog (HH) signaling is how Patched 1 (PTCH1), the receptor for HH
ligands, inhibits Smoothened (SMO), a G-protein-coupled receptor (GPCR) family protein that trans-
duces the HH signal across the membrane (Kong et al., 2019). We and others demonstrated that
cholesterol directly binds and activates SMO and proposed that PTCH1 regulates SMO by restricting
its access to cholesterol (Byrne et al., 2016; Huang et al., 2016; Luchetti et al., 2016). Biochemical
studies show that PTCH1 can bind and efflux sterols from cells (Bidet et al., 2011), and structural
studies highlight the homology of PTCH1 to the cholesterol transporter Niemann-Pick C1 (NPC1)
(Gong et al., 2018; Kong et al., 2019; Kowatsch et al., 2019; Qian et al., 2019; Qi et al., 2019a;
Qi et al., 2018a; Qi et al., 2018b; Zhang et al., 2018). However, the resolution of the PTCH1 cryo-
EM structures is not high enough to distinguish cholesterol from other sterol lipids as PTCH1
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substrates, and PTCH1 transport activity has not yet been demonstrated in a purified system or at
endogenous expression levels in cells.
A challenge to this model is presented by the fact that cholesterol constitutes up to 50% of the
lipid molecules in the plasma membrane (Colbeau et al., 1971; Das et al., 2013; Lange et al.,
1989; Touster et al., 1970): how can such an abundant lipid be kept away from SMO to prevent
inappropriate pathway activation? Indeed, other less abundant lipids can bind and regulate SMO
activity, including oxysterols, phosphoinositides, endocannabinoids and arachidonic acid derivatives
(Arensdorf et al., 2017; Jiang et al., 2016; Khaliullina et al., 2015; Nachtergaele et al., 2012).
Side-chain oxysterols, synthesized through the enzymatic or non-enzymatic oxidation of cholesterol,
are appealing alternatives to cholesterol because of their lower abundance, higher hydrophilicity
and structural similarity to cholesterol (Corcoran and Scott, 2006; Dwyer et al., 2007). To find the
endogenous lipidic activator of SMO, we took an unbiased genetic approach to identify lipid-related
genes whose loss influences the strength of HH signaling.
Results
A focused CRISPR screen targeting lipid-related genes
Using our previously described strategy (Pusapati et al., 2018b) to identify positive and negative
regulators of the HH pathway, we conducted focused loss-of-function CRISPR screens using a cus-
tom library targeting 1244 lipid-related genes compiled by the LIPID MAPS consortium
(Supplementary file 1 provides a list of all genes and guide RNAs in the library). This CRISPR library
targeted all annotated genes encoding enzymes involved in the synthesis or metabolism of lipids as
well as proteins that bind or transport lipids. We used a previously characterized NIH/3T3 cell line
(NIH/3T3-CG) that expresses Cas9 and GFP driven by a HH-responsive fluorescent reporter (GLI-
GFP) (Pusapati et al., 2018b). To ensure that HH signaling in the plasma membranes of these cells
would be sensitive to perturbations of endogenous lipid metabolic pathways, we minimized sterol
uptake from the media by growing the entire population of mutagenized cells in lipoprotein-
depleted media for one week prior to the screen and then further treating with U18666A, a drug
that traps any residual lipoprotein-derived cholesterol in lysosomes (Figure 1A) (Lu et al., 2015). In
the screen for positive regulators, we treated cells with a high, saturating concentration of the ligand
Sonic Hedgehog (HiSHH) and used Fluorescence Activated Cell Sorting (FACS) to collect poor res-
ponders, those with the lowest 10% of GLI-GFP fluorescence (Figure 1A and B; full screen results in
Supplementary file 2). These candidate positive regulators are hereafter referred to as ‘HiSHH-
Bot10%’. In the screen for negative regulators, we treated cells with a low, sub-saturating concentra-
tion of SHH (LoSHH) that activated the reporter to <10% of maximal strength and selected super-
responders, cells with the top 5% of GLI-GFP fluorescence (Figure 1A and C; full screen results in
Supplementary file 3). These candidate negative regulators are hereafter referred to as ‘LoSHH-
Top5%’.
The screens correctly identified all four positive controls included in the library: Smo and Adrbk1
(or Grk2) as positive regulators and Ptch1 and Sufu as negative regulators (Figure 1B and C). In
addition, genes previously known to influence HH signaling (Gnas) and protein trafficking at primary
cilia (Inpp5e) were amongst the most significant hits (Cha´vez et al., 2015; Garcia-Gonzalo et al.,
2015; Regard et al., 2013). In addition to Inpp5e, other genes involved in phosphoinositide metab-
olism (Mtmr3 and Plcb3) were also significant hits. Pla2g3, which encodes a secreted phospholipase,
was identified as a negative regulator of HH signaling, an effect that may be related to its known
role as a suppressor of ciliogenesis (Figure 1D) (Gijs et al., 2015; Kim et al., 2010).
To identify lipid species that influence HH signaling, we analyzed the intersection of all genes
expressed in NIH/3T3-CG cells based on RNAseq and annotated as part of a lipid metabolic path-
way in the Kyoto Encyclopedia of Genes and Genomes (KEGG) (Figure 1D; gene lists used for each
pathway are shown in Supplementary file 4; RNAseq data in Supplementary file 5). Statistically sig-
nificant hits clustered in two major pathways: (1) genes encoding enzymes in the cholesterol biosyn-
thesis pathway were positive regulators of HH signaling and (2) genes encoding enzymes in the
sphingolipid biosynthesis pathway were negative regulators (positive regulators are shown in blue
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Figure 1
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Figure 1. CRISPR screens identify lipid-related genes that influence hedgehog signaling. (A) Flowchart summarizing the screening strategy. Screens for
positive and negative regulators used a high, saturating concentration of SHH (HiSHH, 25 nM) or a low concentration of SHH (LoSHH, 3.2 nM),
respectively. (B and C) Volcano plots of the HiSHH-Bot10% (B) screen for positive regulators and the LoSHH-Top5% (C) screen for negative regulators.
Enrichment is calculated as the mean of all sgRNAs for a given gene in the sorted over unsorted population, with the y-axis showing significance based
Figure 1 continued on next page
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and negative regulators in orange in Figure 1D). We focused on these two pathways for the work
described in the rest of this study.
Enzymes in the cholesterol biosynthesis pathway positively regulate
hedgehog signaling
Mutations in Dhcr7 and Sc5d, which encode enzymes that catalyze the terminal steps in cholesterol
biosynthesis, impair HH signaling in target cells and cause the congenital malformation syndromes
Smith-Lemli-Opitz and lathosterolosis, respectively (Blassberg et al., 2016; Cooper et al., 2003;
Horvat et al., 2011; Porter and Herman, 2011). In addition to these genes, many of the genes
encoding enzymes in the pathway that converts squalene to cholesterol were statistically significant
hits with a FDR-corrected p-value threshold of 0.1 in the HiSHH-Bot10% screen (Figure 2A). Of the
post-squalene cholesterol biosynthesis genes that did not meet this threshold, Nsdhl came close
(FDR-corrected p-value=0.25, Supplementary file 2) and Tm7sf2 is redundant (Sharpe and Brown,
2013), leaving Cyp51 as the only gene that was not identified. CRISPR-mediated loss-of-function
mutations in Lss, required for an early step in the pathway, and in Dhcr7 and Dhcr24, required for
the terminal steps, impaired the transcriptional induction of endogenous Gli1 (an immediate target
gene used as a measure of signaling strength) (Figure 2B and C; CRISPR-edited alleles shown in Fig-
ure 2—figure supplement 1A). Quantitative mass spectrometry measurements and intact cell stain-
ing with a cholesterol-binding probe confirmed that the abundance of cholesterol was reduced in
Dhcr7-/- and Dhcr24-/- cells (Figure 2—figure supplement 1B and C). Conversely, the abundances
of substrates for Dhcr7 and Dhcr24, 7-dehydrocholesterol and desmosterol, respectively, were ele-
vated (Figure 2—figure supplement 1D and E). HH signaling in both Lss-/- and Dhcr7-/- cells, but
not in Dhcr24-/- cells, could be rescued with the addition of exogenous cholesterol, pointing to cho-
lesterol deficiency as the cause of impaired HH signaling (Figure 2B and C). Rescue of HH signaling
defects in Dhcr7-/- cells by exogenous cholesterol has also been demonstrated previously
(Blassberg et al., 2016). We do not yet understand the inability of cholesterol to rescue signaling in
Dhcr24-/- cells.
The results of our unbiased screen highlight the importance of the endogenous post-squalene
cholesterol biosynthetic pathway for HH signaling in target cells. While a simple explanation for this
requirement is that cholesterol activates SMO in response to HH ligands, two additional possibilities
have been discussed in the literature. First, defects in the terminal steps in cholesterol biosynthesis
may lead to accumulation of precursor sterols that inhibit signaling (Porter and Herman, 2011).
However, HH signaling defects caused by mutations in genes that control the earliest steps in the
pathway (Sqle, Lss; Figure 2A) cannot be explained by the accumulation of inhibitory precursor ster-
ols (at least not by intermediates in the synthesis of cholesterol from squalene). The second possibil-
ity is that cholesterol is not the product of this pathway directly relevant to HH signaling. Instead, a
different molecule synthesized from cholesterol, such as an oxysterol, primary bile acid or Vitamin D
derivative, is required (Bijlsma et al., 2006; Corcoran and Scott, 2006; Dwyer et al., 2007). How-
ever, none of the genes encoding enzymes that mediate synthesis of these metabolites (listed in
Supplementary file 4) were identified as significant hits in the HiSHH-Bot10% screen (Figure 1D). A
lone oxysterol synthesis enzyme (CYP7A1) was implicated in an opposite role, a negative regulator,
in the LoSHH-Top5% screen (Figure 1D).
24(S), 25-epoxycholesterol is a unique oxysterol that is not synthesized from cholesterol but rather
made through a shunt pathway that closely parallels the post-squalene cholesterol biosynthesis path-
way (Figure 2A). Exogenously added 24(S), 25-epoxycholesterol can bind and activate SMO, so it
has been proposed that this oxysterol (present at ~1% of the levels of cholesterol in cells) may be an
endogenous SMO agonist regulated by PTCH1 (Qi et al., 2019b; Raleigh et al., 2018). Interest-
ingly, DHCR24 is only used in the Kandutsch-Russell and Bloch pathways for cholesterol synthesis
Figure 1 continued
on the false discovery rate (FDR)-corrected p-value. (D) Screen results analyzed by grouping genes based on the core lipid biosynthetic pathways in
KEGG. In all panels, genes identified as positive and negative regulators are labeled in blue and orange respectively. See Supplementary file 4 for the
full analysis.
DOI: https://doi.org/10.7554/eLife.50051.002
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but not in the shunt pathway for the synthesis of 24(S), 25-epoxycholesterol (Sharpe and Brown,
2013). The fact that loss of DHCR24 blocks HH signaling (Figure 2A and C) without reducing 24(S),
25-epoxycholesterol abundance (Figure 2—figure supplement 1F) suggests that cholesterol rather
than 24(S), 25-epoxycholesterol regulates HH signaling.
In summary, the data from our genetic screen support the view that cholesterol itself, rather than
a precursor or a metabolite, is the endogenous sterol lipid that regulates SMO activation. Caveats of
genetic screens include their inability to identify genes or pathways that are (1) redundant, (2)
required for cell viability or growth, or (3) dependent on non-enzymatic reactions or exogenous mol-
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Figure 2. Enzymes that generate cholesterol positively regulate hedgehog signaling. (A) The post-squalene portion of the cholesterol biosynthetic
pathway, with enzymes colored according to their FDR corrected p-value in our CRISPR screens (see Supplementary files 2 and 3). Two branches of
the pathway (the Kandutsch-Russell and the Bloch pathways) produce cholesterol, while a third shunt pathway produces 24(S), 25-epoxycholesterol.
DHCR24 is the only enzyme that is required for cholesterol biosynthesis, but dispensable for 24(S), 25-epoxycholesterol synthesis. (B and C) HH
signaling strength in Lss-/-, Dhcr7-/- and Dhcr24-/- NIH/3T3 cells was assessed by measuring Gli1 mRNA by quantitative reverse transcription PCR (qRT-
PCR) after treatment with either HiSHH (25 nM) or HiSHH combined with 0.3 mM cholesterol:MbCD complexes. Bars denote the mean value derived
from the four individual measurements shown. Statistical significance was determined by the Mann-Whitney test (B, p-value for HiSHH
treatment = 0.0286, p-value for HiSHH + cholesterol treatment = 0.4857) or the Kruskal-Wallis test (C, p-value for HiSHH treatment = 0.0002, p-value for
HiSHH + cholesterol treatment = 0.0002).
DOI: https://doi.org/10.7554/eLife.50051.013
The following figure supplement is available for figure 2:
Figure supplement 1. Abundance of sterols in Dhcr7-/- and Dhcr24-/- cells.
DOI: https://doi.org/10.7554/eLife.50051.014
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Cellular sphingomyelin suppresses hedgehog signaling
Multiple enzymes in the sphingolipid synthesis pathway were statistically significant hits in the
LoSHH-Top5% screen, indicating these enzymes are negative regulators of HH signaling strength
(Figure 3A). Top hits from this screen include Sptlc2, the first committed step in sphingolipid synthe-
sis from L-serine and palmitoyl-CoA, as well as Sgms1, which converts ceramide to sphingomyelin
(SM). The identification of Sgms1 suggests that SM is the relevant product of the sphingolipid path-
way that attenuates HH signaling.
Because we were unable to isolate viable NIH/3T3 cell lines entirely depleted of SPTLC2 or
SGMS1 protein using CRISPR editing, we used a pharmacological strategy. Myriocin is a fungal anti-
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Figure 3. Enzymes that generate sphingomyelin negatively regulate hedgehog signaling. (A) The pathway for the synthesis of SM, with enzymes
colored according to their FDR corrected p-value in our CRISPR screens. Steps in the pathway blocked by myriocin and fumonisin B1 are denoted in
red. (B) A dose-response curve for SHH in myriocin-treated NIH/3T3 cells compared to control cells treated with vehicle (DMSO) alone. Error bars
represent the standard error of the mean from four replicates. (C) Differentiation of spinal Neuronal Precursor Cells (NPCs) into OLIG2-positive motor
neuron progenitors exposed to either LoSHH (5 nM) or HiSHH (25 nM) was assessed using flow cytometry to measure the fluorescence of a OLIG2-
mKate reporter (n > 5000 cells for each treatment). (D) HH signaling strength in NIH/3T3-CG reporter cells treated with LoSHH (5 nM) or HiSHH (50 nM)
after treatment with myriocin alone or myriocin followed by addition of exogenous egg SM. Each data point represents the mean GLI1-GFP
fluorescence from 250 cells in two independent experiments. (E) HH signaling strength measured in NIH/3T3 cells treated with either LoSHH (5 nM) or
HiSHH (25 nM) in the presence or absence of 50 nM staurosporine to increase SM. Bars denote the mean value derived from the four individual
measurements shown. Statistical significance was determined by the Mann-Whitney test (C, D and E); p-values are: (C) p-value<0.0001 (both
comparisons), (D) p-value=0.0002 (both comparisons), and (E) p-value=0.0286 (both comparisons).
DOI: https://doi.org/10.7554/eLife.50051.011
The following figure supplement is available for figure 3:
Figure supplement 1. Analysis of sphingomyelin levels and their effect on hedgehog signaling.
DOI: https://doi.org/10.7554/eLife.50051.012
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(Courtney et al., 2018; Tafesse et al., 2015). SM depletion by myriocin in NIH/3T3 cells was con-
firmed using both thin-layer chromatography (Figure 3—figure supplement 1A) and flow cytometry
of intact cells stained with a fluorescent protein probe (OlyA_E69A) that binds to total SM on the
outer leaflet of the plasma membrane (Figure 3—figure supplement 1B) (Endapally et al., 2019a).
Myriocin treatment potentiated the response to SHH in NIH/3T3 cells, as measured by the transcrip-
tional induction of Gli1 (Figure 3B). This effect was also observed in two additional cell types. In
mouse embryonic fibroblasts (MEFs), myriocin was sufficient to activate HH signaling even in the
absence of added HH ligands (Figure 3—figure supplement 1C). Mouse spinal neural progenitor
cells (NPCs) differentiate into Olig2-expressing motor neuron progenitors in response to moderate
concentrations of SHH. Myriocin potentiated the effect of SHH on NPCs, substantially reducing the
concentration of SHH required to drive motor neuron differentiation (Figure 3C).
Several control experiments established that the potentiating effect of myriocin on HH signaling
was caused by the depletion of SM, rather than an unrelated effect. First, fumonisin B1, a mycotoxin
structurally distinct from myriocin that inhibits a different step in SM synthesis (Figure 3A), also
amplified HH signaling (Figure 3—figure supplement 1D). Second, the potentiating effect of myrio-
cin on HH signaling could be reversed by the exogenous administration of SM (Figure 3D). Finally,
increasing SM levels in cells using a low-dose of staurosporine had the expected opposite effect:
reduction of HH signaling strength (Figure 3E and Figure 3—figure supplement 1E)
(Maekawa et al., 2016).
Sphingomyelin restrains hedgehog signaling at the level
of Smoothened
SM is localized in the outer leaflet of the plasma membrane (Bretscher, 1972; Murate and Kobaya-
shi, 2016; Verkleij et al., 1973) where it plays key roles in its lateral organization, including the for-
mation of ordered membrane microdomains that can influence protein trafficking, signaling and
other processes (Levental and Veatch, 2016; Simons and Ikonen, 2000; Simons and Ikonen,
1997). Therefore, we looked broadly at the effects of myriocin on HH-relevant phenotypes, paying
particular attention to primary cilia, organelles that are required for HH signaling in vertebrates
(Huangfu et al., 2003). Myriocin did not significantly alter the abundances of the HH pathway pro-
teins GLI3, SMO, SUFU or PTCH1 (Figure 4—figure supplement 1A) and also did not change either
the frequency or the length of primary cilia (Figure 4—figure supplement 1B). Sensitivity of target
cells to HH ligands can be influenced by the ciliary abundances of PTCH1, the receptor for all HH
ligands that inhibits SMO, and by GPR161, a GPCR known to negatively regulate HH signaling
(Mukhopadhyay et al., 2013; Pusapati et al., 2018a; Rohatgi et al., 2007). However, both proteins
were properly localized in the ciliary membrane in myriocin-treated cells and were cleared (as
expected) from cilia in response to SHH addition (Figure 4—figure supplement 1C and D). Thus,
myriocin does not seem to significantly alter ciliary biogenesis, ciliary morphology or ciliary traffick-
ing of receptors that negatively regulate HH signaling.
The SHH-triggered accumulation of SMO in primary cilia is required for initiation of HH signaling
in the cytoplasm (Corbit et al., 2005). Myriocin potentiated SMO ciliary accumulation in NIH/3T3
cells, suggesting that SM depletion enhances SMO activation (Figure 4—figure supplement 1E).
HH signaling in cells treated with myriocin was blocked by the SMO antagonist Vismodegib
(Figure 4A). Myriocin also failed to activate HH signaling in Smo-/- cells (Figure 4—figure supple-
ment 1F). Both observations suggest that myriocin acts on SMO, or at a step upstream of SMO. The
lack of an effect of myriocin on PTCH1 trafficking (Figure 4—figure supplement 1C) led us to focus
on SMO as the target for HH potentiation.
SMO has multiple ligand binding sites: one in the extracellular cysteine-rich domain (CRD) that
binds cholesterol and oxysterols and another in the transmembrane domain (TMD) that binds to
diverse SMO ligands and to sterols (Byrne et al., 2018; Deshpande et al., 2019; Qi et al., 2019b;
Sharpe et al., 2015). Mutations in the CRD site abolish sterol binding and responses to SHH; muta-
tions in the more superficial region of the TMD site prevent SMO activation by synthetic agonists
like Smoothened Agonist (SAG) but do not affect responses to SHH (Figure 4B) (Byrne et al., 2016;
Huang et al., 2016; Luchetti et al., 2016; Xiao et al., 2017). We tested the effects of these muta-
tions on the ability of myriocin to activate HH signaling in Smo-/- MEFs stably expressing SMO var-
iants. Since HH signaling is activated in these cells in response to myriocin alone (Figure 3—figure
supplement 1C), we were able to assess the effects of these mutations without the confounding
Kinnebrew et al. eLife 2019;8:e50051. DOI: https://doi.org/10.7554/eLife.50051 7 of 28
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effects of HH ligands or SMO agonists. Previously defined mutations in the sterol-binding CRD site
(D99A/Y134F, Figure 4B), which abrogate cholesterol binding by disrupting a key hydrogen bond
with the 3b-hydroxyl of cholesterol, reduced myriocin-driven activation (Figure 4C) (Byrne et al.,
2016; Huang et al., 2016; Xiao et al., 2017). In contrast, a mutation (D477G, Figure 4B) in the
TMD site failed to diminish myriocin-induced signaling (Figure 4C). In control experiments, SMO-
D99A/Y134F and SMO-D477G were responsive to SAG and SHH, respectively, demonstrating pro-
tein integrity (Figure 4C) (Luchetti et al., 2016). The fact that point mutations in SMO abrogated
the effect of SM depletion suggests that myriocin influences HH signaling at the level of SMO.
Sphingomyelin restrains hedgehog signaling by sequestering
cholesterol
The observation that mutations in the CRD of SMO, a well-defined binding site for cholesterol
(Byrne et al., 2016), attenuated the effects of SM depletion (Figure 4C) suggested that SM regu-
lates SMO activity by controlling the availability of cellular cholesterol that can bind to SMO. There
is a precedent for SM regulation of cholesterol availability in another cellular signaling context– the
control of cholesterol synthesis (Das et al., 2014; Scheek et al., 1997; Slotte and Bierman, 1988).
These studies have led to the proposal that plasma membrane cholesterol is organized in three
pools: a fixed pool essential for membrane integrity, a SM-sequestered pool with low chemical activ-
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Figure 4. Sphingomyelin depletion potentiates hedgehog signaling at the level of Smoothened. (A) HH signaling triggered by HiSHH (25 nM) in the
presence or absence of Vismodegib (2.5 mM) in NIH/3T3 cells treated with myriocin. (B) Human SMO in complex with cholesterol (PDB 5L7D)
highlighting two residues in the CRD (D95 and Y130) critical for cholesterol binding and a residue (D473) in the transmembrane domain (TMD) critical
for binding to the agonist SAG. Numbering for mouse SMO, used in our studies, is denoted in parenthesis. (C) HH signaling triggered by myriocin
alone in Smo-/- MEFs stably expressing the indicated variants of mouse SMO. A control experiment (right) shows that the SMO variants respond
appropriately to either SAG (100 nM) or SHH (50 nM), demonstrating protein integrity. Note that the D477G and D99A/Y134F mutations abrogate
responses to SAG and SHH, respectively (Luchetti et al., 2016). In (A) and (C), bars denote the mean value derived from the measurements shown
(n = 4 for A, n = 2–4 in C). Statistical significance (p-value=0.0286 for both A and C) was determined by the Mann-Whitney test.
DOI: https://doi.org/10.7554/eLife.50051.003
The following figure supplement is available for figure 4:
Figure supplement 1. The effect of myriocin treatment on the abundances of hedgehog pathway components and on ciliary protein trafficking.
DOI: https://doi.org/10.7554/eLife.50051.004
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proteins and transport to the ER (Das et al., 2014; Lange et al., 2004; Radhakrishnan et al., 2000).
The distribution of cholesterol between the sequestered and accessible pools is determined by the
ratio of cholesterol to SM: SM depletion (or cholesterol addition) leads to an increase in accessible
cholesterol (Figure 5A) (Das et al., 2014). These different pools of cholesterol are characterized by
differences in the chemical activity (or accessibility) of membrane cholesterol and thus cannot be
measured by mass spectrometry, which extracts total cholesterol from cell membranes with solvents
irrespective of the cholesterol’s chemical activity. Instead, protein probes derived from lipid-binding
toxins have been recently developed to distinguish between the accessible and sequestered pools
in intact membranes or cells (Figure 5A): PFO*, derived from the bacterial toxin Perfringolysin O,
binds to the accessible pool of cholesterol and OlyA, derived from the fungal toxin Osterolysin A,
binds to SM-cholesterol complexes (Das et al., 2013; Endapally et al., 2019a; Flanagan et al.,
2009; Skocˇaj et al., 2014). A useful point mutant of OlyA (OlyA_E69A) binds to both free SM and
SM-cholesterol complexes, allowing measurement of total SM (Figure 5A) (Endapally et al., 2019a).
To test these probes in NIH/3T3 cells, we used flow cytometry to measure the binding of fluores-
cently-labeled PFO*, OlyA and OlyA_E69A to intact cells either treated with myriocin to deplete SM
or loaded with exogenous cholesterol (known to increase accessible cholesterol levels in cells;
Das et al., 2014). Treatment of cells with myriocin decreased both OlyA and OlyA_E69A staining,
consistent with SM depletion (Figure 5B and C); staining was restored by the addition of exogenous
egg SM (Figure 5D). Myriocin treatment and cholesterol loading increased PFO* staining, showing
that both treatments increased the level of accessible cholesterol in the plasma membrane
(Figure 5E). The depletion of SM with myriocin or other pharmacological agents does not change
the abundances of total cellular cholesterol or plasma membrane cholesterol (Das et al., 2014;
Tafesse et al., 2015).
We sought to test the model that SM depletion by myriocin potentiates HH signaling by increas-
ing the pool of accessible cholesterol. Reducing accessible cholesterol in myriocin-treated cells with
methyl-b-cyclodextrin (MbCD), measured by PFO* staining, decreased SHH-induced activation of
the GLI-GFP reporter (Figure 5F). This rescue is not consistent with the alternative possibility that
SM negatively regulates SMO either directly or through a different mechanism.
These results, together with the requirement of the cholesterol-binding CRD for the potentiating
effect of myriocin (Figure 4C), support the model that SM impairs HH signaling by sequestering cho-
lesterol into complexes where it is inaccessible to SMO. This conclusion is also consistent with the
observation that purified SMO is constitutively active in nano-discs containing physiological levels of
cholesterol in the absence of SM (Myers et al., 2017). In summary, the effects of SM depletion with
myriocin are reminiscent of those when cells are loaded with cholesterol: accessible cholesterol lev-
els increase and HH signaling is potentiated (Das et al., 2014; Huang et al., 2016; Luchetti et al.,
2016).
Accessible cholesterol regulates hedgehog signaling
As an orthogonal approach to test the importance of accessible cholesterol without using myriocin,
we used the cholesterol binding domain of the bacterial toxin anthrolysin O (ALOD4) (Gay et al.,
2015). Unlike a reagent like MbCD, which extracts cholesterol from cells, ALOD4 selectively traps
accessible cholesterol on the outer leaflet of the plasma membrane without altering cholesterol lev-
els in the cell or plasma membrane (Figure 6A) (Infante and Radhakrishnan, 2017). Despite very
different mechanisms of action, both ALOD4 and MbCD blocked HH signaling when added to cells
(Figure 6B). In a control experiment, ALOD4 induced the expression of Hmgcr, the gene encoding
the enzyme HMG-CoA reductase, which is known to be induced when accessible cholesterol is
depleted (Figure 6C) (Infante and Radhakrishnan, 2017; Johnson et al., 2019). ALOD4 did not
change the frequency of ciliation (Figure 6D).
In summary, HH signaling is enhanced by myriocin, which increases accessible cholesterol
(Figure 5E), but inhibited by ALOD4, which decreases accessible cholesterol. Neither myriocin nor
ALOD4 change total cholesterol abundance in cells (Infante and Radhakrishnan, 2017;
Tafesse et al., 2015). We conclude that accessible cholesterol is the thermodynamically distinct frac-
tion of total cholesterol that is relevant for the regulation of SMO in HH signaling.
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Figure 5. Reducing accessible cholesterol in myriocin-treated cells impairs hedgehog signaling. (A) Cholesterol and SM form SM-cholesterol complexes
in which cholesterol is sequestered and prevented from interacting with proteins like SMO. The ratio of SM to cholesterol determines the level of
accessible cholesterol (free from SM). Protein probes detecting the various pools of cholesterol and SM are shown: PFO* binds to accessible
cholesterol, OlyA to SM-cholesterol complexes and OlyA_E69A to both free SM and SM-cholesterol complexes. (B–E) Flow cytometry of intact cells
stained with fluorescently-labeled OlyA_E69A (B and D), OlyA (C) or PFO* (E) after the indicated treatments (n > 4000 cells for each condition). (F)
HiSHH-induced (50 nM) GLI1-GFP reporter fluorescence in NIH/3T3-CG cells treated with myriocin alone or myriocin followed by 0.4 mM MbCD to
reduce accessible cholesterol levels. The graph on the right shows whole cell fluorescence of cells stained with PFO* to measure accessible cholesterol
in the outer leaflet of the plasma membrane. Each data point denotes the mean fluorescence of GLI1-GFP or PFO* staining calculated from ~200 cells
from two separate experiments and the bars denote the mean value. Statistical significance was determined by the Mann-Whitney test (B–F); p-values
are: (B) p-value=0.9486 for control vs cholesterol treated cells and p-value<0.0001 for control vs myriocin treated cells, (C) p-value<0.0001 (both
comparisons), (D) p-value<0.0001 (all comparisons), (E) p-value<0.0001 (control vs cholesterol and control vs myriocin) and p-value=0.0195 for
cholesterol vs myriocin, (F) p-value<0.0001 for GLI-GFP fluorescence comparison and p-value=0.0002 for PFO* comparison.
DOI: https://doi.org/10.7554/eLife.50051.005
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The ciliary membrane is a compartment with low cholesterol
accessibility
The regulation of SMO by PTCH1 occurs at primary cilia, the only post-Golgi compartment in the
cell where both proteins can be found localized together (Rohatgi et al., 2009; Rohatgi et al.,
2007). Since the ciliary membrane is thought to have a different lipid and protein composition than
the plasma membrane (Nachury and Mick, 2019), we compared PFO*, OlyA and OlyA_E69A stain-
ing in the ciliary membrane relative to the plasma membrane using confocal microscopy. Controls
confirmed that these probes could be used to measure levels of cholesterol, SM-cholesterol com-
plexes and total SM in the ciliary membrane using quantitative fluorescence microscopy (Figure 7—
figure supplement 1A–1C), analogous to how we used them to measure these species at the
plasma membrane by flow cytometry (Figure 5B–5E).
For each cilium visualized by confocal microscopy, we calculated the ratio of mean ciliary fluores-
cence to mean plasma membrane fluorescence in a region surrounding the cilium (hereafter the ‘C/P
ratio’) (Geneva et al., 2017). We used this metric because myriocin treatment or cholesterol loading
will lead to changes in probe staining at both the plasma membrane and the ciliary membrane. The
C/P ratio reflects changes in the ciliary membrane relative to changes in the plasma membrane: if
probe staining increases by the same factor in the plasma membrane and the ciliary membrane the
C/P ratio will remain unchanged.
In untreated cells, the C/P ratio was significantly higher for OlyA_E69A staining compared to
OlyA or PFO* staining (Figure 7A). This suggests that the ratio of SM to cholesterol, which deter-
mines the abundance of accessible cholesterol, is high in the ciliary membrane. Indeed, while
































































































Figure 6. ALOD4 impairs hedgehog signaling by trapping accessible cholesterol. (A) ALOD4 and MbCD reduce accessible cholesterol by different
mechanisms. ALOD4 binds and traps accessible cholesterol in the outer leaflet of plasma membranes of intact cells, without changing total cholesterol
abundance. MbCD removes cholesterol from membranes, reducing both accessible and total cholesterol. (B) HH signaling triggered by five hours of
LoSHH (5 nM) or HiSHH (30 nM) treatment following pre-treatment of cells with ALOD4 (3 or 9 mM) or MbCD (2 mM) for 1 hour. Bars denote the mean
value derived from the four individual measurements shown. (C) Hmgcr mRNA levels measured with qRT-PCR after treatment with the same conditions
as in (B). Bars denote the mean value derived from the eight individual measurements shown. (D) Ciliation frequency of cells after ALOD4 treatment
(same conditions as in B), calculated as the number of cilia over the number of nuclei. Each point represents the ciliation frequency (derived from >30
cells) in a different imaging field. Statistical significance was determined by the Mann-Whitney test (B–D); p-values are: (B) p-value=0.0286 (all
comparisons), (C) p-value=0.0002 for both comparisons, and (D) p-value=0.4857.
DOI: https://doi.org/10.7554/eLife.50051.006
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show distinctive staining for SM-cholesterol complexes (OlyA) or accessible cholesterol (PFO*)
(Figure 7D). Cholesterol loading increased the C/P ratio of SM-cholesterol complexes (OlyA stain-
ing, Figure 7B and D), showing that a significant proportion of SM molecules at cilia are free to pair
with exogenously added cholesterol. Myriocin treatment, which reduced SM levels in both the
plasma membrane and the ciliary membrane (Figure 5B and Figure 7—figure supplement 1A),
increased the amount of accessible cholesterol in the ciliary membrane relative to the plasma mem-
brane (PFO* staining, Figure 7C and D). Indeed, myriocin had a greater effect on the C/P ratio of
accessible cholesterol compared to even cholesterol loading, suggesting that SM provides the major
restraint on cholesterol accessibility at cilia (Figure 7C). Taken together, we conclude that the ratio
of sphingomyelin to cholesterol is high in the ciliary membrane, leading to low cholesterol accessibil-

































































































































































































Figure 7. Primary cilia have high sphingomyelin and low accessible cholesterol. (A–C) Ratio of mean ciliary staining intensity to mean plasma membrane
staining intensity (the C/P ratio, see text) for OlyA_E69A, OlyA, or PFO* (see Figure 5A) in NIH/3T3 cells left untreated (A) or treated with either
myriocin (80 mM) or cholesterol-MbCD complexes (B and C) (A-C, n > 30 cilia per condition). (D) Representative images of individual primary cilia from
cells stained with each of the lipid probes (colored blue) after the indicated treatments. Cells stably expressed ARL13B-GFP (colored red) to allow the
identification of cilia. Scale bar: one micron. Statistical significance was determined by the Kruskal-Wallis test (A and C) or the Mann-Whitney test (B); all
p-values are <0.0001.
DOI: https://doi.org/10.7554/eLife.50051.007
The following figure supplement is available for figure 7:
Figure supplement 1. Sphingomyelin depletion increases accessible cholesterol at cilia.
DOI: https://doi.org/10.7554/eLife.50051.008
Kinnebrew et al. eLife 2019;8:e50051. DOI: https://doi.org/10.7554/eLife.50051 12 of 28
Research advance Cell Biology Developmental Biology
ciliary membrane is significantly more resistant (compared to the plasma membrane) to permeabili-
zation by both PFO and cholesterol-binding detergents like digitonin (Breslow et al., 2013).
High SM levels may be critical for keeping SMO, which is cycling through the ciliary membrane
even in the absence of SHH, in an inactive state by restricting its access to cholesterol (Ocbina and
Anderson, 2008). Reducing SM levels with myriocin (or increasing cholesterol levels by cholesterol
loading) increases accessible cholesterol in the ciliary membrane and, consequently, potentiates
SMO activation. Conversely, reducing accessible cholesterol abundance with ALOD4 or MbCD pre-
vents SMO activation (Figure 6).
Hedgehog ligands cause an increase in cholesterol accessibility at
primary cilia
PTCH1, the receptor for HH ligands, is thought to inhibit SMO by reducing its access to cholesterol
using its transporter-like activity. Since PTCH1 is localized in and around the cilium, we have pro-
posed that it could function to inhibit SMO by reducing accessible cholesterol in the ciliary mem-
brane (Huang et al., 2016; Kong et al., 2019; Luchetti et al., 2016). The concept that PTCH1 can
alter the membrane environment of primary cilia is also suggested by the observation that the move-
ment and distribution of single molecules of PTCH1 and SMO in the ciliary membrane can be altered
by SHH or by cholesterol depletion with MbCD (Weiss et al., 2019). This model predicts that SHH,
which inhibits PTCH1 activity, should lead to an increase in accessible cholesterol and PFO* staining
at the ciliary membrane. Given the potential artifacts associated with overexpressing a transporter
protein, we sought to measure changes in accessible cholesterol at endogenous PTCH1 expression
levels.
SHH did not induce much of a change in PFO* staining of the bulk plasma membrane, measured
by flow cytometry (Figure 8A). A lack of an effect is not surprising because changes in overall choles-
terol accessibility would influence many other cellular processes, including the signaling system that
maintains cholesterol homeostasis (Brown et al., 2018; Brown and Goldstein, 2009; Steck and
Lange, 2010). In contrast, SHH led to a rapid increase in accessible cholesterol in the ciliary mem-
brane, either when cells were treated with myriocin or when cells were loaded with cholesterol
(Figure 8B and C). SHH did not change ciliary PFO* staining in Ptch1-/- cells (Figure 8—figure sup-
plement 1A). In addition, activation of signaling with SAG, which bypasses PTCH1 and directly acti-
vates SMO, also did not cause significant changes in accessible cholesterol at the ciliary membrane
(Figure 8—figure supplement 1B). Both controls show that the SHH-induced change in accessible
cholesterol at primary cilia is dependent on PTCH1 activity.
Discussion
The results of our unbiased screen for lipid-related genes that influence the strength of HH signaling
uncovered two pathways– cholesterol and SM synthesis– that both converge on accessible choles-
terol as the critical species that regulates the interaction between PTCH1 and SMO. The potentiat-
ing effect of SM depletion on HH signaling points to cholesterol itself as the regulatory sterol, since
side-chain oxysterols do not form analogous complexes with SM (and the lipid probes used in our
studies do not interact with oxysterols) (Endapally et al., 2019a; Slotte, 2016). Two features explain
how a seemingly abundant membrane lipid like cholesterol can play an instructive role as a second
messenger in a signaling pathway. First, only a fraction of total plasma membrane cholesterol is rele-
vant to the regulation of HH signaling. This thermodynamically distinct pool of accessible cholesterol
with high chemical activity ranges from ~2% of total plasma membrane cholesterol in lipid depleted
cells to ~15% of total plasma membrane cholesterol in lipid replete cells (Das et al., 2014). Second,
the changes in accessible cholesterol that regulate SMO are confined to a subcellular compartment,
the primary cilium, where PTCH1, SMO and the cytoplasmic signaling machinery downstream of
SMO are localized. Phosphoinositides and oxysterols are examples of other lipids whose abundances
in the ciliary membrane are different from the plasma membrane (Cha´vez et al., 2015; Garcia-
Gonzalo et al., 2015; Raleigh et al., 2018), supporting the general principle that the lipid composi-
tion of primary cilia may be dynamically altered to control the activity or trafficking of cilia-localized
proteins (Nachury and Mick, 2019). Further work will be required to determine if cholesterol acces-
sibility is a second messenger specific to HH regulation at cilia or whether it can also influence other
Kinnebrew et al. eLife 2019;8:e50051. DOI: https://doi.org/10.7554/eLife.50051 13 of 28



















































































































































Figure 8. PTCH1 decreases the pool of accessible cholesterol at primary cilia. (A) Flow cytometry was used to measure plasma membrane PFO*
staining in intact cells after HiSHH treatment (n > 4000 cells per violin). Fold changes of median values (SHH treated over untreated) are indicated (A
and B). (B) PFO* staining at primary cilia after the addition of HiSHH in cells treated with myriocin (80 mM), cholesterol:MbCD complexes or left
untreated (n > 65 cilia per condition). (C) Representative images of primary cilia from cells treated with myriocin with or without the addition of HiSHH.
Figure 8 continued on next page
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membrane proteins, including many other GPCRs, that function in the privileged compartment
formed by the ciliary membrane.
The strategy of confining changes in abundance of a second messenger to a subcellular compart-
ment or microdomain is used in other signaling pathways, such as those that use cAMP or calcium.
Confinement allows small changes in absolute numbers of a regulatory molecule to be amplified into
larger changes in concentration and also insulates other cellular processes from being inappropri-
ately impacted (because second messengers are often used in multiple pathways). Another pathway
that detects and responds to accessible cholesterol is the SCAP/SREBP signaling system, which pro-
vided an important precedent (and inspiration) for our work (Brown et al., 2018; Brown and Gold-
stein, 2009). SCAP senses accessible cholesterol in a specific subcellular compartment, the
endoplasmic reticulum (ER), to regulate the transcription of genes that control cholesterol biosynthe-
sis (Radhakrishnan et al., 2008; Sokolov and Radhakrishnan, 2010). Continual transport of choles-
terol from the plasma membrane to the ER ensures that information about changes in plasma
membrane cholesterol accessibility is transmitted to the ER, where SCAP is localized (Infante and
Radhakrishnan, 2017). While cholesterol accessibility has been proposed to regulate diverse mem-
brane proteins (Lange and Steck, 2016), our work provides the first clear evidence that it functions
as an instructive signal in a system other than the one regulating cholesterol homeostasis.
Our work raises the important question of how PTCH1, presumably using its transporter function,
reduces the levels of accessible cholesterol in the ciliary membrane (Figure 8B). In principle, PTCH1
could accomplish this either by increasing ciliary levels of SM or by decreasing ciliary levels of choles-
terol. PTCH1 is more likely to be a sterol transporter for several reasons: it has homology to the cho-
lesterol transporter NPC1 and the spate of recent PTCH1 structures have identified putative sterol
ligands (Gong et al., 2018; Qian et al., 2019; Qi et al., 2019a; Qi et al., 2018a; Qi et al., 2018b;
Zhang et al., 2018). We suggest that PTCH1 may selectively transport the pool of accessible choles-
terol (rather than the fixed or SM-bound pool) to a yet unknown membrane or protein acceptor
(Figure 8D). This would allow PTCH1 to maintain low cholesterol accessibility in a membrane com-
partment without depleting it entirely of cholesterol. Selective transport of accessible cholesterol
has been previously proposed for other cholesterol transporter proteins (Lange and Steck, 2016).
The direction of sterol transfer by PTCH1 remains uncertain: it could transport cholesterol in the
same direction as its relative NPC1 (from the ciliary membrane to a sterol transport protein or a
membrane compartment in the cytoplasm) or in an outward direction from the ciliary membrane to
an extracellular acceptor (see arrows labeled 1 and 2 in Figure 8D). The prominent localization of
PTCH1 at and around the base of primary cilia (Rohatgi et al., 2007) raises the possibility that
PTCH1 functions at the ciliary pocket to deplete accessible cholesterol from the ciliary membrane
(Figure 8D). The cholesterol pumping activity of PTCH1 will be opposed by the continual leak of
cholesterol back into the cilium from the large pool in the plasma membrane (since the ciliary mem-
brane is continuous with the plasma membrane) or by the delivery of cholesterol from sterol binding
proteins in the cytoplasm. This ‘pump-leak’ model may be energetically sustainable because PTCH1
is tasked with reducing accessible cholesterol only over the small surface area of the ciliary mem-
brane (~400 fold smaller than that of the plasma membrane) (Nachury, 2014). When PTCH1 is inacti-
vated by HH ligands, accessible cholesterol levels in primary cilia will rapidly rise due to unopposed
lateral movement from the plasma membrane or delivery from cytosolic sterol transfer proteins,
resulting in SMO activation.
Figure 8 continued
Scale bar: one micron. (D) Model depicting how PTCH1 could inhibit SMO at primary cilia by decreasing accessible cholesterol in the ciliary membrane
(see Discussion for details). PTCH1 could transport cholesterol from the ciliary membrane to an intracellular acceptor (1) or to an extracellular acceptor
(2). PTCH1 inactivation leads to an increase in accessible cholesterol in both leaflets of the ciliary membrane, leading to SMO activation through the
CRD and TMD sterol-binding sites. Statistical significance was determined by the Mann-Whitney test (B); p-values are: NoSHH vs HiSHH p-
value=0.5984, cholesterol treated NoSHH vs HiSHH p-value=0.0008, myriocin treated NoSHH vs HiSHH 15 min p-value<0.0001 and 24 hour p-
value=0.0277.
DOI: https://doi.org/10.7554/eLife.50051.009
The following figure supplement is available for figure 8:
Figure supplement 1. SHH- induced changes in accessible cholesterol levels at cilia are dependent on PTCH1 activity.
DOI: https://doi.org/10.7554/eLife.50051.010
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In this model, the level of SM in the ciliary membrane determines the set-point for how much cho-
lesterol needs to be transported by PTCH1 to reduce accessible cholesterol below the threshold
required to activate SMO. Depleting SM (or loading cells with cholesterol) raises the demands on
PTCH1 transport activity and hence makes cells hyper-sensitive to PTCH1-inactivating HH ligands. In
some cell types (MEFs, see Figure 3—figure supplement 1C), PTCH1 cannot completely overcome
the effect of SM depletion, leading to SMO activation even in the absence of any SHH. The emphasis
in this model on the SM-cholesterol ratio accounts for the observation that either SM depletion
(Figure 3B) or cholesterol loading (Huang et al., 2016; Luchetti et al., 2016) synergizes with HH
ligands to activate signaling. Our focus on SM was driven by the results of our screen, but we note
that other phospholipids can also complex cholesterol and may reduce its chemical activity at the cil-
iary membrane (Keller et al., 2000; Lange et al., 2013; McConnell and Radhakrishnan, 2003).
SMO has two potential cholesterol-binding sites: one in the CRD (tested in Figure 4C) and a sec-
ond deep in the TMD (Byrne et al., 2016; Deshpande et al., 2019; Huang et al., 2018;
Luchetti et al., 2016; Qi et al., 2019a). Mutations in either site prevent the activation of signaling
by HH ligands, implicating both in the regulation of SMO by PTCH1. The extracellular CRD site
is ~12 angstroms away from the outer leaflet of the plasma membrane (Luchetti et al., 2016), while
the TMD site has been proposed to obtain cholesterol from the inner leaflet through an opening
between two transmembrane helices (Deshpande et al., 2019; Huang et al., 2018). In the latter
case, PTCH1 has been proposed to inhibit SMO by reducing cholesterol abundance in the inner leaf-
let of the plasma membrane (Zhang et al., 2018).
SM is confined to the outer leaflet of the plasma membrane and thus its depletion will directly
increase accessibility of cholesterol in the outer leaflet (Murate and Kobayashi, 2016; Steck and
Lange, 2018). The non-lytic sensors used throughout our work are added to intact cells and hence
monitor levels of accessible cholesterol, SM, and SM-cholesterol complexes in the outer leaflet only.
However, SM depletion (or cholesterol loading) will also increase the abundance of cholesterol in
the inner leaflet of the plasma membrane because cholesterol rapidly redistributes between the two
leaflets of the plasma membrane by flip-flop movement (Steck and Lange, 2018). Cholesterol flip-
flop between the inner and outer leaflets also means that exogenously added ALOD4 will trap
accessible cholesterol in the outer leaflet but will also consequently reduce cholesterol levels in the
inner leaflet (Infante and Radhakrishnan, 2017). Thus, SM depletion (or ALOD4 addition) can influ-
ence cholesterol access to either the CRD or the TMD sites in SMO (Figure 8D). Our experiments
cannot distinguish between whether inner or outer leaflet cholesterol is more relevant to SMO
activation.
We end with a speculative answer to an enigma in HH signaling: why is the HH pathway depen-
dent on primary cilia in vertebrates but not in Drosophila? The predominant sterol in Drosophila is
ergosterol, with cholesterol itself representing <5% of membrane sterols (Rietveld et al., 1999). In
addition, flies are cholesterol auxotrophs: they acquire cholesterol from their diet and have lost
many of the genes for cholesterol biosynthesis (Carvalho et al., 2010; Vinci et al., 2008). Thus, flies
do not need the regulatory machinery that monitors accessible cholesterol in the plasma membrane
and adjusts the transcription of cholesterol biosynthetic genes. The SREBP pathway, which monitors
accessible cholesterol in vertebrates, has been repurposed in Drosophila to respond to phosphati-
dylethanolamine (Dobrosotskaya et al., 2002). Cholesterol levels in Drosophila are instead sensed
by a distinct nuclear receptor-based mechanism (Bujold et al., 2010). We propose that the lack of a
need to regulate cholesterol biosynthetic pathway genes abrogates the need to confine HH signal-
ing to primary cilia in insects.
Materials and methods
Key resources table
Provided in Supplementary file 6.
Reagents
Suppliers for chemicals included Sigma-Aldrich (U18666A, cholesterol, Methyl-b-cyclodextrin
(MbCD), fatty acid free Bovine Serum Albumin (BSA), Atto-647N maleimide); Cayman Chemicals
(Myriocin, Fumonisin B1), Calbiochem (Staurosporine), Avanti Polar Lipids (Egg sphingomyelin),
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Matreya LLC (Milk sphingomyelin), Enzo Life Sciences (SAG), LC Labs (Vismodegib) and Invitrogen
(Alexa-647 NHS ester). Primary (SMO, PTCH1, SUFU, GLI1, GLI3 and P38) and secondary antibodies
(Peroxidase AffiniPure Donkey Anti-Mouse, Rabbit and Goat IgG) used for Western Blotting were
previously described (Pusapati et al., 2018b). Human SHH was expressed and purified as described
previously (Bishop et al., 2009). Reagents used for cell culture are discussed in the methods for Cell
Culture and Drug Treatments.
Guide RNA library targeting lipid-related genes
In order to generate a lipid-library, human lipid-modifying genes/proteins were downloaded from
the LIPID MAPS Proteome Database (https://www.lipidmaps.org/data/proteome/LMPD.php). Using
Entrez IDs, these human gene names/IDs were converted to their mouse homologs using a database
from the Mouse Genome Informatics (MGI). Any human genes not found in the MGI database were
manually confirmed to not have a mouse homolog and excluded from the library, or, if a mouse
homolog existed for the human gene, it was added to the target gene list. Missing genes were sup-
plemented manually. This resulted in a list of 1244 mouse lipid-related genes. Finally, Ptch1, Sufu,
Smo, and Adrbk1 (Grk2) were added to the target gene list as positive controls. Using lists from the
Brie Mouse CRISPR Knockout Pooled library (Doench et al., 2016) and the GeCKO v2 Mouse
CRISPR Knockout Pooled library (Sanjana et al., 2014), guide RNA (sgRNA) sequences were
extracted. The guide count per gene ranged from 4 to 10. Approximately 15 genes had no guides in
the Brie or GeCKO libraries. For these genes, 10 guide sequences were designed using the Broad
Institute’s CRISPR Design tool (https://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-
design). The final target gene list contained 11,783 guides targeting 1248 genes. 200 non-targeting
control guides were added to this final list from the GeCKO v2 library, resulting in a total of 11,983
guides for the library. The library of guides was synthesized using Twist Bioscience’s Oligo Pools and
cloned into lentiGuide Puro vector (a gift from Feng Zhang; Addgene plasmid #52963) as described
previously (Joung et al., 2017).
CRISPR/Cas9 screen targeting lipid-related genes
Our reporter-based screening platform has been described previously in detail (Lebensohn et al.,
2016; Pusapati et al., 2018b). NIH/3T3-CG cells were used because they respond to SHH in a con-
centration-dependent manner, carry stably integrated Cas9, and carry fluorescence-based, quantita-
tive reporter of HH signaling (GLI-GFP) (Pusapati et al., 2018b). This reporter allows the isolation of
cell populations with enhanced or reduced HH signaling phenotypes by FACS. CRISPR library ampli-
fication, lentiviral production, functional titer determination and transduction were carried out as
previously described in detail (Joung et al., 2017; Pusapati et al., 2018b).
To prepare the library of cells for screening, 4  15 cm plates were seeded with 5 million cells
each. These cells were then grown for 1 week in ‘supplemented DMEM’ (see Materials and methods
section on Cell Culture and Drug Treatments) containing 5% Lipoprotein Depleted Serum (LDS) in
place of 10% Fetal Bovine Serum. This treatment was carried out so that cells would become reliant
on their own endogenous lipid-biosynthesis machinery. Finally, cells were grown to confluence in 5%
LDS DMEM and then serum starved in 0.5% LDS DMEM and treated with 1 mM U18666A and either
left untreated (NoSHH) or treated with LoSHH (3.2 nM) or HiSHH (25 nM) for 24 hr. Cells were then
trypsinized, 4 million were pelleted and frozen for the unsorted control population, and the
remaining ~25 million cells (representing 2000-fold coverage of the sgRNA library) were sorted for
the lowest 10% (HiSHH-Bottom10% screen) or highest 5% of GFP fluorescence (HiSHH-Top5%
screen). Finally, genomic DNA was extracted from the unsorted and sorted cells and the sgRNA
library was amplified by nested PCR, subjected to Illumina sequencing, and analyzed using the
MAGeCK algorithm as described previously (Li et al., 2014; Pusapati et al., 2018b).
Kyoto encyclopedia of genes and genomes (KEGG) analysis of lipid
pathways
In order to determine which lipids influence hedgehog signaling, mouse-specific genes were manu-
ally curated into lists for each lipid metabolic pathway identified on the Kyoto Encyclopedia of Genes
and Genomes (KEGG) website (Supplementary file 4). Since oxysterol pathways are not a separate
category in KEGG, manual curation of the literature was used to identify 34 oxysterol-related
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enzymes (see Supplementary file 4), 6 of which were not found in the KEGG database (Abdel-
Khalik et al., 2018; Griffiths et al., 2019; Griffiths et al., 2017; Griffiths and Wang, 2018;
Raleigh et al., 2018; Sever et al., 2016). For each gene identified in KEGG or the oxysterol list,
FDR-corrected p-values were extracted from the HiSHH-Bot10% screen (Supplementary file 2) as
well as the LoSHH-Top5% screen (Supplementary file 3). Finally, the expression level of each gene
was obtained from RNAseq analysis (performed in duplicate and RPKM normalized) carried out in
NIH/3T3 cells (Supplementary file 5). If a gene was not expressed (RPKM value of 0 in both RNAseq
data sets), it was not included in the pathway analysis of Figure 1D.
Cell culture and drug treatments
NIH/3T3-CG Reporter Cells used in the CRISPR screen (and in Figure 3D and 5F), Smo-/- MEFs sta-
bly expressing SMO mutants (WT, D477G and D99A/Y134F), NIH/3T3 Flp-In cells stably expressing
GPR161-YFP, mouse HM1 mESCs, and Ptch1-/- cells have been previously described and character-
ized (Luchetti et al., 2016; Pusapati et al., 2018a; Pusapati et al., 2018b; Rohatgi et al., 2007).
NIH/3T3 Flp-In cells were purchased from Thermo Fisher Scientific, NIH/3T3 cells from ATCC, and
HM1 mESCs from Open Biosystems and used at low passages for experiments. These purchased
cells lines came with a certificate of authentication from the vendor and were used without further
validation. Cell lines were confirmed to be negative for Mycoplasma infection. In the NIH/3T3 Flp-In
background, Lss-/-, Dhcr7-/- and Dhcr24-/- clonal cell lines were generated using a two-cut CRISPR
strategy using methods described in our previous publications (Pusapati et al., 2018a;
Pusapati et al., 2018b) and validated using a PCR-based genotyping strategy (Figure 2—figure
supplement 1A and Supplementary file 6). NIH/3T3 cells and Ptch-/- MEFs (Rohatgi et al., 2007)
stably expressing ARL13B C-terminally tagged with GFP were generated by lentiviral infection fol-
lowed by puromycin (Calbiochem) selection.
All cells were grown in high glucose Dulbecco’s Modified Eagle’s Medium (DMEM) (Thermo
Fisher Scientific) containing the following supplements (hereafter referred to as ‘supplemented
DMEM’): 10% Fetal Bovine Serum (FBS) (Sigma), 1 mM sodium pyruvate (Gibco), 2 mM L-glutamine
(Gemini Biosciences), 1x MEM nonessential amino acids solution (Gibco), penicillin (40 U/ml) and
streptomycin (40 micrograms/ml) (Gemini Biosciences). To induce ciliation, cells were grown to con-
fluence and then the cell media was exchanged to low serum (0.5% FBS) supplemented DMEM. In
order to test the requirement for cholesterol in hedgehog signaling, Dhcr7-/- and Dhcr24-/- NIH/3T3
cells were cultured for 1 week prior to experiments in supplemented DMEM containing 5% Lipopro-
tein-Depleted Serum (LDS) in place of 10% FBS (Kalen Biomedical, LLC). To induce ciliation and test
for SHH responsiveness, cells were serum starved in 0.5% LDS supplemented DMEM and simulta-
neously treated with 1 mM U18666A and various concentrations of SHH in the presence or absence
of exogenously added cholesterol:MbCD complexes for 24 hr. Due to their inability to survive with
prolonged exposure to LDS-containing DMEM, Lss-/- cells were cultured for 2 days in 5% LDS media
prior to overnight treatment with 1 mM U18666A, SHH, and cholesterol:MbCD complexes for hedge-
hog signaling assays. Two or more independent clonal Dhcr7-/-, Dhcr24-/- and Lss-/- cell lines were
tested in all assays and gave similar results (Figure 2B–2C). Note that the SHH-responsiveness of
Dhcr7-/-, Dhcr24-/- and Lss-/- cells was similar to wild-type cells when cultured in media containing
lipid-replete serum.
In order to deplete cells of SM, myriocin (40 mM, unless otherwise indicated) and fumonisin B1 (40
mM) were added to cells cultured in 10% FBS DMEM for three days prior to HH signaling assays,
flow cytometry, or microscopy. Low-dose staurosporine (50 nM), egg SM: fatty acid free BSA com-
plexes (30 mM), MbCD (0.3 mM), cholesterol:MbCD complexes (0.3 mM), and SHH ligands were all
added for 24 hr before analysis unless otherwise indicated. Vehicle controls (such as DMSO for Myr-
iocin and fatty acid free BSA for SM add-back experiments) were used when appropriate. Choles-
terol:MbCD complexes were generated as described previously (Luchetti et al., 2016). Egg
sphingomyelin: fatty acid free BSA complexes were made by dissolving in Optimem (Gibco) at a
molar ratio of 1000:1 (sphingomyelin:BSA) followed by water-bath sonication.
Neural progenitor differentiation assays
To assess the effect of myriocin on hedgehog (HH) signaling in a more physiological, differentiation-
based assay, we used the HM1 mESC line described previously (Pusapati et al., 2018a). This cell
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line harbors the GLI1-Venus and OLIG2-mKate dual reporter system to evaluate the strength of HH
signaling output both through Gli1 target gene induction and the Olig2 differentiation marker for
motor neuron progenitors. After growth and maintenance of mESC on feeder cells, the cells were
plated on 6-well gelatin-coated CellBIND plates (Corning) at a density of 100,000 cells/well for flow
cytometry analysis. Differentiation was carried out in N2B27 media (Dulbecco’s Modified Eagle’s
Medium F12 (Gibco) and Neurobasal Medium (Gibco) (1:1 ratio) supplemented with N-2 Supplement
(Gibco), B-27 Supplement (Gibco), 1% penicillin/streptomycin (Gemini Bio-Products), 2 mM L-gluta-
mine (Gemini Biosciences), 40 mg/mL Bovine Serum Albumin (Sigma), and 55 mM 2-mercaptoetha-
nol (Gibco)). Cells were first plated (Day 0) in N2B27 medium supplemented with 10 ng/mL bFGF (R
and D). One day later (Day 1), either 40 mM myriocin or vehicle control (DMSO) was added to the
culture media. On Day 2, media was replaced with bFGF-supplemented media (with or without myr-
iocin) containing 5 mM CHIR99021 (Axon). On Day 3, cells were cultured in N2B27 medium contain-
ing 100 nM RA (Sigma-Aldrich) (with or without myriocin) and either left untreated (NoSHH) or
treated with LoSHH (5 nM) or HiSHH (25 nM). A fresh medium change with the same ingredients
was done on Day 4 and Day 5. Finally, on Day 6, cells were washed with PBS and trypsinized for flow
cytometry analysis. OLIG2-mKate fluorescence was measured on a FACScan Analyzer at the Stanford
FACS core facility. A 561 nm laser was used for excitation and emission was collected with a filter
centered at 615 nm with a 25 nm bandpass.
Hedgehog signaling assays
Gli1 mRNA transcript levels were measured using the Power SYBR Green Cells-to-CT kit (Thermo
Fisher Scientific). Gli1 levels relative to Gapdh were calculated using the Delta-Ct method (CT(Gli1) -
CT(Gapdh)). The RT-PCR was carried out using custom primers for Gli1 (forward primer: 50-ccaagc-
caactttatgtcaggg-30 and reverse primer: 50-agcccgcttctttgttaatttga-30), and Gapdh (forward primer:
50-agtggcaaagtggagatt-30 and reverse primer: 50-gtggagtcatactggaaca-30). For analysis of GLI1-GFP
in NIH/3T3-CG cells by flow cytometry, cells were harvested by trypsinization and incubated with
media containing 0.5% FBS at 4˚C. Cells were either analyzed by flow cytometry immediately or col-
lected by centrifugation and processed for staining with the various lipid probes. All lipid probes
were labeled with far-red fluorescent dyes (Alexa or Atto 647, see below), so GLI-GFP reporter fluo-
rescence and probe staining could be measured simultaneously by two-channel flow cytometry. Dur-
ing flow cytometry, forward and side scatter plots were used to select a live cell population largely
composed of single cells and this population was then analyzed without any further gating selection.
GFP fluorescence (for the GLI-GFP reporter) was measured using a Sony Cell Sorter Model SH800S
(Figure 3D) with a 488 nm laser for excitation; emitted fluorescence was measured by first excluding
wavelengths lower than 487.5 nm and higher than 561 nm and then collecting with a filter centered
at 525 nm and a 50 nm bandpass. In Figure 5F, the GFP fluorescence was measured on a BD Acuri
C6 Flow Cytometer using an 473 nm laser for excitation and a 520/30 nm bandpass filter to collect
emitted light.
Purification and labeling of lipid probes
Mutant His6-tagged Perfringolysin O (PFO*) was purified as previously described (Das et al., 2014)
and covalently labeled with Alexa Fluor 647 following the manufacturer’s instructions. Expression,
purification and labeling of His6-tagged OlyA and His6-tagged OlyA_E69A was carried out as
described previously (Endapally et al., 2019a). Briefly, both proteins were expressed in Escherichia
coli Rosetta(DE3)pLysS cells, purified by metal-affinity and gel-filtration chromatography and their
lone cysteines labelled with Atto-647 maleimide following the manufacturer’s instructions (Sigma
Aldrich, product #05316). Expression and purification of His6- and FLAG-tagged domain 4 of anthro-
lysin O (ALOD4) was carried out as described previously (Endapally et al., 2019b).
Measurement of whole-cell lipid probe staining by flow cytometry
To stain cells with these labeled probes, they were harvested for flow cytometry by trypsinization fol-
lowed by quenching in ice-cold low (0.5% FBS) serum supplemented DMEM. All subsequent steps
were completed on ice. Cells were spun at 1000 g and then resuspended in Probe Blocking Buffer
(PBB, 1x PBS with 10 mg/mL BSA). After 10 min in PBB, cells were spun and then resuspended in
PBB containing desired probes at the following final concentrations: 5 mg/mL PFO*, 2 mM OlyA and
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2 mM OlyA_E69A. Cells were stained for 1 hr and then washed three times in PBB before flow
cytometry.
Flow cytometry to measure fluorescence from probes bound to intact cells was carried out on a
Sony Cell Sorter Model SH800S (Figure 2—figure supplement 1B, Figure 3—figure supplement
1B and E, Figure 5B–5E, Figure 8A and Figure 5F). Live, singlet cell populations were selected
based on forward and side scatter only and analyzed without any further gating. A 638 nm laser was
used for excitation, and emission was measured by first excluding wavelengths lower than 639 nm
and higher than 685 nm and then collecting using a 665/30 nm bandpass filter.
Measurement of ciliary probe staining by microscopy
Probe staining at cilia was carried out using NIH/3T3 or Ptch-/- cells stably expressing ARL13B-GFP
as a cilia marker to avoid the use of detergents for permeabilization. For PFO* probe staining, the
coverslips were transferred to an ice-cold metal rack and intact cells were stained with PFO* (at a
final concentration of 5 mg/mL) diluted into ice cold low (0.5% FBS) serum supplemented DMEM for
30 min. For OlyA and OlyA_E69A probe staining, live cells were stained at room temperature in
probe (at a final concentration of 2 mM for both OlyA and OlyA_E69A) diluted in room temperature
low (0.5% FBS) serum supplemented DMEM for 10 min. After staining, cells were washed with 1x
PBS and then immediately fixed in 4% PFA in 1xPBS for 10 min. Coverslips were then washed three
times with 1x PBS and mounted on glass slides in ProLong Diamond Antifade Mountant (Thermo
Fisher Scientific) where they cured overnight at room temperature before imaging.
Thin layer chromatography
Cells grown in the presence or absence of myriocin (40 mM for 3 days) were harvested by washing
with 4˚C 1x PBS, scraping and spinning at 1000 g. Lipids were extracted using chloroform/methanol/
water (2:2:1). Lipid extracts were loaded onto a TLC plate (Millipore) along with egg and milk sphin-
gomyelin as lipid standards. The plate was run in a chloroform/acetone/methanol/acetic acid/water
(6:8:2:2:1) solvent system, visualized with a 0.03% Coomassie blue G, 100 mM NaCl, 30% methanol
solution, and destained with a 100 mM NaCl and 30% methanol solution (Courtney et al., 2018).
Analysis of lipid probe staining at cilia by immunofluorescence
Images were obtained using a Leica TCS SP5 confocal imaging system containing a 63x oil immer-
sion objective. Quantification of probe staining at cilia was performed using code written in MATLAB
R2014b using the following steps. Leica Image Files (LIF) were converted into matrices using the
bfmatlab toolbox. Following a max-z-projection, cilia were identified by applying a two-dimensional
median filter followed by a high-pass user-defined threshold for signal versus noise to generate a
cilia mask in the cilia channel. Any group of contiguous pixels that had signal was labeled as a
‘potential cilium.’ Each potential cilium was then subjected to a series of tests (measuring area,
eccentricity, solidity, intensity, and length). If each test was passed, the ‘true cilium’ pixels were then
mapped to a matrix containing the pixels in the lipid probe channel. In the lipid probe channel, each
focal plane was measured independently to avoid noise caused by probe staining outside of the
focal plane of a given cilium. The average intensity of pixels falling within a given cilia mask was mea-
sured for each focal plane and these values were recorded in a matrix. In order to measure the local
plasma membrane fluorescence around each cilium, the cilia mask was dilated to a user-defined size,
and the initial cilia mask was subtracted from the dilated cilia mask in order to create the ‘plasma
membrane mask.’ Plasma membrane probe staining was then measured by averaging the pixel
intensities within the plasma membrane mask in each focal plane. To generate the final intensity
value for each cilium, the focal plane containing the highest average ciliary probe staining was nor-
malized (either by subtraction or division when specified) to the focal plane containing the highest
average plasma membrane probe staining. This MATLAB code is available on GitHub (https://
github.com/mkinnebr/lipids-HH; Kinnebrew, 2019; copy archived at https://github.com/elifescien-
ces-publications/lipids-HH).
Measurement of sterol abundances by mass spectrometry
For sterol measurements, cells were grown in 6 cm plates under conditions identical to those used
for the screens and for the HH signaling assays shown in Figure 2. Cells were extensively washed
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with cold 1X PBS and harvested by scraping and centrifugation. One-tenth of each cell population
was saved for genomic DNA measurement and the remainder was snap frozen in liquid nitrogen and
processed for cholesterol, desmosterol, 7-dehydrocholesterol and 24(S), 25-epoxycholesterol meas-
urements by mass spectrometry according to protocols described previously (McDonald et al.,
2012). Genomic DNA was harvested from 1/10th of the cell population using the PureLink Genomic
DNA Mini Kit (Thermo Fisher Scientific) and quantitated using the Qubit dsDNA High Sensitivity Kit
(Thermo Fisher Scientific). For each sample, the sterol measurement was divided by the DNA mea-
surement to correct for differences in cell number.
Statistical analysis
Statistical analysis was conducted in consultation with Alex McMillan, PhD (Department of Biomedi-
cal Data Science, Stanford University School of Medicine). Data analysis and visualization were per-
formed in GraphPad Prism 8. Model figures (Figures 1A, 5A, 6A and 8D) and biosynthesis flow
diagrams (Figures 2A and 3A) were made in Adobe Illustrator CS6. Immunofluorescence images
were made in Fiji-2 and the Smoothened structure (Figure 4B, PDB 5L7D) was generated in MacPy-
MOL. RNAseq data were analyzed in Partek Flow, and analysis of the screen data was performed
using a published pipeline (code available at https://github.com/RohatgiLab/BAIMS-Pipeline). Violin
plots were generated with default settings in GraphPad Prism 8; outliers were excluded using the
Identify Outlier function of GraphPad Prism 8 (ROUT method with a Q-score = 10%). Mean and
interquartile range for the data in each violin is marked by solid and dotted lines, respectively.
All statistical analyses used non-parametric methods, which do not assume an underlying normal
distribution in the data. The statistical significance of differences between two groups was deter-
mined by the Mann-Whitney test and between three or more groups by the Kruskal-Wallis test. Infor-
mation about error bars, statistical tests, p values and n values are reported in each figure legend
and were calculated using GraphPad Prism 8. All experiments included at least three independent
trials with consistent results, with the exception of the CRISPR genetic screens: The HiSHH screen
was performed twice and the LoSHH screen was performed once.
Throughout the paper, the numerical p-values for the comparisons from GraphPad Prism eight
are given in the figure legends and denoted on the graphs according to the following key: *p-val-
ue0.05, **p-value0.01, ***p-value0.001, ****p-value0.0001, non-significant (ns) p-value>0.05.
Data availability
The complete list of genes and guide RNAs used in the targeted CRISPR genetic screen is given in
Supplementary file 1. The complete list of hits from the screens are given in Supplementary files 2
and 3. The annotated pathways compiled manually from the Kyoto Encyclopedia of Genes and
Genomes (KEGG) are given in Supplementary file 4. RNAseq data are given in Supplementary file
5.
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